Goldline Pharmaceutical Share Price
18 Nov, 2026 3:03 PM (IST)
Goldline Pharmaceutical Performance
- Today's Low
- ₹29
- Today's High
- ₹29
- 52 Week Low
- ₹28
- 52 Week High
- ₹60
- Open Price₹29
- Previous Close₹29
- Volume6,000
- 50 DMA₹33.50
- 100 DMA₹37.90
- 200 DMA-
Goldline Pharmaceutical Chart
Investment Returns
- Over 1 Month -10.71%
- Over 3 Month -27.66%
Smart Investing Starts Here Start SIP with Goldline Pharmaceutical for Steady Growth!
Goldline Pharmaceutical Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 6.8
- PEG Ratio
- -
- Market Cap Cr
- 28
- P/B Ratio
- 2.1
- Average True Range
- 1.5
- EPS
- 4.3
- Dividend Yield
- 0
- MACD Signal
- -1.1
- RSI
- 39.31
- MFI
- 45.74
Latest Stock News Updates
Submission of statement of deviation and variation of the half year ended 30th september 2026
- BSE India
- 3 days 19 hours ago
Declaration of Un-audited Standalone Financial Results of the company for the half year ended September 30, 2026
- BSE India
- 3 days 19 hours ago
Outcome of Board Meeting dated 14th November, 2026 pursuant to Reg 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 & Submission of Un-audited Standalone Financial Results of the Company for the half year ended September 30, 2026.
- BSE India
- 3 days 19 hours ago
Goldline Pharmaceutical Financials
Goldline Pharmaceutical Technicals
EMA & SMA
- Bearish Moving Average 13
- Bullish Moving Average 0
- 20 Day
- ₹30.90
- 50 Day
- ₹33.50
- 100 Day
- ₹37.90
- 200 Day
- -
Resistance and Support
- R3 31.00
- R2 30.50
- R1 29.70
- S1 28.30
- S2 27.90
- S3 27.00
Goldline Pharmaceutical Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-11-14 | Half Yearly Results | |
| 2026-06-09 | Audited Results |
About Goldline Pharmaceutical
Goldline Pharmaceutical are engaged in the business of marketing pharmaceutical products under the brand name “Goldline.” View More- NSE Symbol
- GLPL
- BSE Symbol
- 544759
- ISIN
- INE1CLW01015
Similar Stocks to Goldline Pharmaceutical
Popular Stocks
Goldline Pharmaceutical FAQs
Goldline Pharmaceutical share price is ₹29 As on 18 November, 2026 | 15:02
The Market Cap of Goldline Pharmaceutical is ₹27.8 Cr As on 18 November, 2026 | 15:02
The P/E ratio of Goldline Pharmaceutical is 6.8 As on 18 November, 2026 | 15:02
The PB ratio of Goldline Pharmaceutical is 2.1 As on 18 November, 2026 | 15:02
The 52 week High & Low of Goldline Pharmaceutical is ₹60/₹28.1 respectively As on 18 November, 2026 | 15:02
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.